Mapping of Metabolic Heterogeneity of Glioma Using MR-Spectroscopy.

Proton magnetic resonance spectroscopy (H-MRS) delivers information about the non-invasive metabolic landscape of brain pathologies. H-MRS is used in clinical setting in addition to MRI for diagnostic, prognostic and treatment response assessments, but the use of this radiological tool is not entirely widespread. The importance of developing automated analysis tools for H-MRS lies in the possibility of a straightforward application and simplified interpretation of metabolic and genetic data that allow for incorporation into the daily practice of a broad audience.